Real-world test of automated insulin delivery in primary care
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests if an automated insulin delivery system (the iLet bionic pancreas) works well in real-world primary care settings for people with type 1 or type 2 diabetes. It aims to see if this technology can help manage blood sugar more easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 88 years old
- You have type 1 diabetes for at least 1 year, or type 2 diabetes and have been using insulin for at least 3 months
- Your diabetes and weight loss medications have been stable for the past 4 weeks
- You have a primary care doctor who will refer you and help manage your diabetes during the study
- You are willing to use a Dexcom continuous glucose monitor, an iLet bionic pancreas, and specific insulins (lispro or aspart)
- You have internet access and can do video calls
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study tests whether a treatment can help your pancreas make more insulin and possibly put your type 2 diabetes into remission. It is for people diagnosed with type 2 diabetes in the last 5 years who are already on diabetes medication.
This study compares two ways to manage blood sugar in the hospital for people with type 2 diabetes: an automated insulin delivery system (a pump worn on the body with a continuous glucose monitor) versus the usual daily insulin injections. The goal is to see if the automated system keeps blood sugar in a safer range during an acute illness.
This study is testing the iLet Bionic Pancreas System in people with type 1 diabetes. It looks at how well the system works in your daily life and asks you to share your glucose data and answer surveys.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.